171 related articles for article (PubMed ID: 25620439)
1. Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.
Adams AS; Soumerai SB; Zhang F; Gilden D; Burns M; Huskamp HA; Trinacty C; Alegria M; LeCates RF; Griggs JJ; Ross-Degnan D; Madden JM
Clin Ther; 2015 Mar; 37(3):597-609. PubMed ID: 25620439
[TBL] [Abstract][Full Text] [Related]
2. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
Adams AS; Madden JM; Zhang F; Lu CY; Ross-Degnan D; Lee A; Soumerai SB; Gilden D; Chawla N; Griggs JJ
Value Health; 2017 Dec; 20(10):1345-1354. PubMed ID: 29241894
[TBL] [Abstract][Full Text] [Related]
3. Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.
Adams AS; Madden JM; Zhang F; Soumerai SB; Gilden D; Griggs J; Trinacty CM; Bishop C; Ross-Degnan D
Med Care; 2014 Aug; 52(8):695-703. PubMed ID: 24988304
[TBL] [Abstract][Full Text] [Related]
4. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Sambamoorthi U; Olfson M; Walkup JT; Crystal S
Med Care; 2003 Jan; 41(1):180-94. PubMed ID: 12544554
[TBL] [Abstract][Full Text] [Related]
5. Racial-ethnic disparities in use of antidepressants in private coverage: implications for the Affordable Care Act.
Jung K; Lim D; Shi Y
Psychiatr Serv; 2014 Sep; 65(9):1140-6. PubMed ID: 24828481
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in adherence to antidepressant treatment in later life.
Kales HC; Nease DE; Sirey JA; Zivin K; Kim HM; Kavanagh J; Lynn S; Chiang C; Neighbors HW; Valenstein M; Blow FC
Am J Geriatr Psychiatry; 2013 Oct; 21(10):999-1009. PubMed ID: 23602306
[TBL] [Abstract][Full Text] [Related]
7. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
Wu CH; Erickson SR; Piette JD; Balkrishnan R
Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
[TBL] [Abstract][Full Text] [Related]
8. A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.
Carson NJ; Progovac AM; Wang Y; Cook BL
Depress Anxiety; 2017 Dec; 34(12):1147-1156. PubMed ID: 28962069
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in the treatment of depression in low-income persons with diabetes.
Osborn CY; Trott HW; Buchowski MS; Patel KA; Kirby LD; Hargreaves MK; Blot WJ; Cohen SS; Schlundt DG
Diabetes Care; 2010 May; 33(5):1050-4. PubMed ID: 20185741
[TBL] [Abstract][Full Text] [Related]
10. Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and whites?
Schneider EC; Cleary PD; Zaslavsky AM; Epstein AM
JAMA; 2001 Sep; 286(12):1455-60. PubMed ID: 11572737
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with antidepressant use among low-income racially and ethnically diverse patients with type 2 diabetes.
Presley CA; White RO; Bian A; Schildcrout JS; Rothman RL
J Diabetes Complications; 2019 Oct; 33(10):107405. PubMed ID: 31405797
[TBL] [Abstract][Full Text] [Related]
12. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
[TBL] [Abstract][Full Text] [Related]
13. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
14. Differences in the cost of antidepressants across state Medicaid programs.
Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
[TBL] [Abstract][Full Text] [Related]
15. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression.
Donohue JM; Zhang Y; Aiju M; Perera S; Lave JR; Hanlon JT; Reynolds CF
Am J Geriatr Psychiatry; 2011 Dec; 19(12):989-97. PubMed ID: 22123272
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of the Use of Antidepressant Treatment Between Non-Hispanic Black and White and Mexican American Adults With Type 2 Diabetes in the United States.
Perez A; Cabrera P; Gutierrez C; Valdes J
Diabetes Educ; 2017 Apr; 43(2):171-179. PubMed ID: 28340545
[TBL] [Abstract][Full Text] [Related]
17. Racial-Ethnic Differences in Off-Label Antidepressant Use, by Insurance Type.
Lim D; Jung J
Psychiatr Serv; 2017 Dec; 68(12):1271-1279. PubMed ID: 28806891
[TBL] [Abstract][Full Text] [Related]
18. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression.
Strothers HS; Rust G; Minor P; Fresh E; Druss B; Satcher D
J Am Geriatr Soc; 2005 Mar; 53(3):456-61. PubMed ID: 15743289
[TBL] [Abstract][Full Text] [Related]
19. Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees.
Adams AS; Zhang F; LeCates RF; Graves AJ; Ross-Degnan D; Gilden D; McLaughlin TJ; Lu C; Trinacty CM; Soumerai SB
Arch Intern Med; 2009 Apr; 169(8):750-6. PubMed ID: 19398686
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression.
Sambamoorthi U; Walkup J; Olfson M; Crystal S
J Gen Intern Med; 2000 May; 15(5):311-20. PubMed ID: 10840266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
